Effects of a one-year physical activity program on serum C-terminal Agrin Fragment (CAF) concentrations among mobility-limited older adults - 06/12/24

Doi : 10.1007/s12603-015-0474-3 
I. Bondoc 1, S.K. Cochrane 1, T.S. Church 2, P. Dahinden 3, S. Hettwer 3, F.-C. Hsu 4, R.S. Stafford 5, M. Pahor 1, Thomas W. Buford 1,
For the Life Study Investigators
1 Translational Exercise, Aging, and Muscle Laboratory, Department of Aging and Geriatric Research, University of Florida, 32611, Gainesville, FL, USA 
2 Pennington Biomedical Research Institute, Baton Rouge, LA, USA 
3 Neurotune AG, Schlieren, Zurich, Switzerland 
4 Wake Forest School of Medicine, Winston-Salem, NC, USA 
5 Stanford University, Palo Alto, CA, USA 

j352-273-5918, 352-273-5920

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Abstract

Objectives

C-terminal Agrin Fragment (CAF) has been proposed as a potential circulating biomarker for predicting changes in physical function among older adults. To determine the effect of a one-year PA intervention on changes in CAF concentrations and to evaluate baseline and longitudinal associations between CAF concentrations and indices of physical function.

Design

Ancillary study to the Lifestyle Interventions and Independence for Elders Pilot (LIFE-P), a multi-site randomized clinical trial designed to evaluate the effects of chronic exercise on the physical function of older adults at risk for mobility disability.

Setting

Four academic research centers within the U.S.

Participants

Three hundred thirty three older adults aged 70 to 89 with mild to moderate impairments in physical function.

Intervention

A 12-month intervention of either structured physical activity (PA) or health education promoting successful aging (SA).

Measurements

Serum CAF concentrations and objectives measures of physical function — i.e. gait speed and performance on the Short Physical Performance Battery (SPPB).

Results

The group*time interaction was not significant for serum CAF concentrations (p=0.265), indicating that the PA intervention did not significantly reduce serum CAF levels compared to SA. Baseline gait speed was significantly correlated with baseline CAF level (r = −0.151, p= 0.006), however the association between CAF and SPPB was not significant. Additionally, neither baseline nor the change in CAF concentrations strongly predicted the change in either performance measure following the PA intervention.

Conclusion

In summary, the present study shows that a one-year structured PA program did not reduce serum CAF levels among mobility-limited older adults. However, further study is needed to definitively determine the utility of CAF as a biomarker of physical function.

El texto completo de este artículo está disponible en PDF.

Key words : Aging, physical function, neuromuscular function, mobility, LIFE study


Esquema


© 2015  © 2015 SERDI Publisher.. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 19 - N° 9

P. 922-927 - novembre 2015 Regresar al número
Artículo precedente Artículo precedente
  • Effects of changes in regional body composition on physical function in older adults: A pilot randomized controlled trial
  • A.J. Santanasto, A.B. Newman, E.S. Strotmeyer, R.M. Boudreau, B.H. Goodpaster, Nancy W. Glynn
| Artículo siguiente Artículo siguiente
  • Preliminary findings of the Brief Everyday Activities Measurement (BEAM) in older adults
  • E.A. Scharaga, Roee Holtzer

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.